Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery

Background Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia...

Full description

Saved in:
Bibliographic Details
Published inAnesthesiology (Philadelphia) Vol. 133; no. 4; pp. 764 - 773
Main Authors Makito, Kanako, Matsui, Hiroki, Fushimi, Kiyohide, Yasunaga, Hideo
Format Journal Article
LanguageEnglish
Published 01.10.2020
Online AccessGet full text

Cover

Loading…
Abstract Background Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery. Methods The authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery. Results The authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery. Conclusions Overall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New
AbstractList Background Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery. Methods The authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery. Results The authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery. Conclusions Overall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New
BACKGROUNDPrevious experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery. METHODSThe authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery. RESULTSThe authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery. CONCLUSIONSOverall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors. EDITOR’S PERSPECTIVE
Author Makito, Kanako
Matsui, Hiroki
Fushimi, Kiyohide
Yasunaga, Hideo
Author_xml – sequence: 1
  givenname: Kanako
  surname: Makito
  fullname: Makito, Kanako
– sequence: 2
  givenname: Hiroki
  surname: Matsui
  fullname: Matsui, Hiroki
– sequence: 3
  givenname: Kiyohide
  surname: Fushimi
  fullname: Fushimi, Kiyohide
– sequence: 4
  givenname: Hideo
  surname: Yasunaga
  fullname: Yasunaga, Hideo
BookMark eNpdUMtKA0EQHETBJPoHHuboZeM893EM8ZFA0IDR69LZ9K4jm5k4s1nI3zshCmJfii6qi64aknPrLBJyw9mYsyK7myyex-zPSKXYGRlwLfKE80yfk8GRTSQT4pIMQ_iMa6ZlPiDbd9dCZ1qkPfqwD3TlOmjp3HYeerQuMhOLofvAYIDWztMp2Ao9XXrXWBdMoMbSZbRA2wU6g97Yht6bJt6YHn_Vr3vfoD9ckYsa2oDXPzgib48Pq-ksWbw8zaeTRVKJQrBEpUVa6YzzdSGVkAo4pFyqtQAQMpd6AxtQNaaYsUrWKgbhEXOd5ZjrNQo5Ircn3513X_v4Srk1ocK2BYsxUimUErlSmWZRqk7SyrsQPNblzpst-EPJWXlst4ztlv_bld9c928z
CitedBy_id crossref_primary_10_1097_MD_0000000000029169
crossref_primary_10_1016_j_bja_2022_03_019
crossref_primary_10_3389_fonc_2021_686294
crossref_primary_10_3389_fonc_2024_1397197
crossref_primary_10_1016_j_heliyon_2024_e24791
crossref_primary_10_1016_j_biopha_2021_111991
crossref_primary_10_1097_ACO_0000000000001261
crossref_primary_10_1186_s12871_022_01703_8
crossref_primary_10_1007_s12630_023_02653_6
crossref_primary_10_5492_wjccm_v13_i2_92751
crossref_primary_10_1097_ALN_0000000000004309
crossref_primary_10_1111_aas_13791
crossref_primary_10_3892_or_2022_8465
crossref_primary_10_1186_s13063_022_06157_4
crossref_primary_10_17085_apm_24041
crossref_primary_10_1097_MD_0000000000030840
crossref_primary_10_3390_cancers15010209
crossref_primary_10_1002_advs_202102079
crossref_primary_10_3390_jcm13103017
crossref_primary_10_1097_ALN_0000000000003804
crossref_primary_10_3389_fonc_2022_759057
crossref_primary_10_1007_s11912_022_01342_9
crossref_primary_10_3389_fonc_2022_960299
crossref_primary_10_3390_cells12202503
crossref_primary_10_1007_s00423_021_02078_z
crossref_primary_10_3389_fphar_2021_685265
crossref_primary_10_3724_abbs_2022067
crossref_primary_10_1007_s11605_021_05037_7
crossref_primary_10_1016_j_bja_2023_01_023
crossref_primary_10_1097_ACO_0000000000001274
crossref_primary_10_1177_15330338221121092
crossref_primary_10_1186_s12871_023_02023_1
crossref_primary_10_3389_fonc_2021_788918
crossref_primary_10_1097_ALN_0000000000004132
crossref_primary_10_1590_1806_9282_2024s102
crossref_primary_10_3390_jpm11121358
crossref_primary_10_3389_fmed_2021_658926
crossref_primary_10_3390_cancers13153654
crossref_primary_10_1097_EA9_0000000000000021
crossref_primary_10_1155_2023_7443226
crossref_primary_10_1186_s12871_023_02400_w
crossref_primary_10_3389_fphar_2022_1057571
crossref_primary_10_1007_s00540_023_03288_z
crossref_primary_10_1016_j_bjao_2022_100005
crossref_primary_10_3389_fonc_2021_793093
crossref_primary_10_3389_fonc_2022_708632
crossref_primary_10_1186_s12957_023_02891_4
crossref_primary_10_1097_ACO_0000000000001002
crossref_primary_10_1097_SLA_0000000000005568
crossref_primary_10_1016_j_addr_2021_05_023
crossref_primary_10_1007_s11912_022_01282_4
crossref_primary_10_3389_fonc_2022_837959
crossref_primary_10_3390_cancers13143390
crossref_primary_10_1097_ALN_0000000000003510
crossref_primary_10_1111_anae_15582
crossref_primary_10_1016_j_bja_2023_07_027
crossref_primary_10_1097_ACO_0000000000001049
crossref_primary_10_1007_s40140_023_00605_w
crossref_primary_10_4097_kja_22584
crossref_primary_10_1186_s12871_023_02308_5
crossref_primary_10_3390_curroncol30010091
crossref_primary_10_1186_s13014_022_02000_x
crossref_primary_10_4097_kja_22747
crossref_primary_10_1097_ALN_0000000000004119
crossref_primary_10_1177_1073274820965575
Cites_doi 10.1097/MD.0000000000005479
10.1146/annurev.publhealth.19.1.17
10.1186/s12982-018-0069-7
10.1093/bja/aet581
10.1007/s10555-016-9647-8
10.18632/oncotarget.8304
10.1080/03610910902859574
10.1038/bjc.2014.426
10.1016/j.bja.2017.11.066
10.1097/ALN.0000000000000936
10.1093/aje/kwq433
10.1097/ALN.0b013e31829e47fd
10.1007/s10753-013-9671-6
10.2307/2171753
10.1016/j.ejphar.2018.04.009
10.1093/bja/aeu200
10.3892/or.2016.5218
10.1007/s12630-019-01381-0
10.1097/EDE.0000000000000279
10.1016/j.je.2016.09.009
10.3892/or.2017.5514
10.1016/j.jclinane.2017.08.001
10.2147/OTT.S156792
10.1097/ALN.0000000000002491
10.3109/03009734.2014.922649
10.7314/APJCP.2014.15.16.6703
ContentType Journal Article
DBID AAYXX
CITATION
7X8
DOI 10.1097/ALN.0000000000003440
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
EISSN 1528-1175
EndPage 773
ExternalDocumentID 10_1097_ALN_0000000000003440
GroupedDBID ---
-~X
.-D
.XZ
.Z2
01R
026
0R~
1CY
1J1
23M
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6J9
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
AAYXX
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLED
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
AE3
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHVBC
AHXIK
AIJEX
AINUH
AJIOK
AJNWD
AJRGT
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BAWUL
BCGUY
BOYCO
BQLVK
BYPQX
C45
CITATION
CS3
DIK
DIWNM
E.X
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF7
JK3
JK8
K-A
K-F
K8S
KD2
KMI
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OB3
OBH
ODA
ODMTH
ODZKP
OGROG
OHH
OHYEH
OJAPA
OK1
OL1
OLB
OLG
OLH
OLL
OLU
OLV
OLW
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RIG
RLZ
S4R
S4S
TEORI
TR2
TSPGW
TWZ
V2I
W2D
W3M
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
ZFV
ZY1
7X8
ACLDA
ID FETCH-LOGICAL-c2920-4696c5711b934234a1a6134b2aa23835dada4fe6e70c3f45381c3f8578e85be23
ISSN 0003-3022
IngestDate Fri Oct 25 00:08:05 EDT 2024
Fri Aug 23 01:45:36 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2920-4696c5711b934234a1a6134b2aa23835dada4fe6e70c3f45381c3f8578e85be23
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://pubs.asahq.org/anesthesiology/article-pdf/133/4/764/515065/20201000.0-00020.pdf
PQID 2442844750
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_2442844750
crossref_primary_10_1097_ALN_0000000000003440
PublicationCentury 2000
PublicationDate 20201001
PublicationDateYYYYMMDD 2020-10-01
PublicationDate_xml – month: 10
  year: 2020
  text: 20201001
  day: 01
PublicationDecade 2020
PublicationTitle Anesthesiology (Philadelphia)
PublicationYear 2020
References Swanson (2021080915435765800_R27) 2015; 26
Lousdal (2021080915435765800_R26) 2018; 15
Yap (2021080915435765800_R10) 2019; 66
Iwasaki (2021080915435765800_R18) 2016; 7
Benzonana (2021080915435765800_R1) 2013; 119
Jiang (2021080915435765800_R4) 2018; 831
Yang (2021080915435765800_R19) 2017; 37
Zheng (2021080915435765800_R24) 2018; 11
Newhouse (2021080915435765800_R14) 1998; 19
Yoo (2021080915435765800_R23) 2019; 130
Desmond (2021080915435765800_R3) 2015; 35
Ciechanowicz (2021080915435765800_R17) 2018; 120
Yang (2021080915435765800_R20) 2017; 37
Liu (2021080915435765800_R8) 2016; 95
Quan (2021080915435765800_R12) 2011; 173
Liu (2021080915435765800_R9) 2014; 15
Yamana (2021080915435765800_R11) 2017; 27
Wigmore (2021080915435765800_R22) 2016; 124
Huang (2021080915435765800_R16) 2014; 111
Soltanizadeh (2021080915435765800_R21) 2017; 42
Baki (2021080915435765800_R7) 2013; 36
Buckley (2021080915435765800_R2) 2014; 113 Suppl 1
Staiger (2021080915435765800_R15) 1997; 65
Austin (2021080915435765800_R13) 2009; 38
Kim (2021080915435765800_R5) 2017; 36
Jaura (2021080915435765800_R6) 2014; 113 Suppl 1
Enlund (2021080915435765800_R25) 2014; 119
References_xml – volume: 95
  start-page: e5479
  year: 2016
  ident: 2021080915435765800_R8
  article-title: Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer.
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000005479
  contributor:
    fullname: Liu
– volume: 19
  start-page: 17
  year: 1998
  ident: 2021080915435765800_R14
  article-title: Econometrics in outcomes research: The use of instrumental variables.
  publication-title: Annu Rev Public Health
  doi: 10.1146/annurev.publhealth.19.1.17
  contributor:
    fullname: Newhouse
– volume: 15
  start-page: 1
  year: 2018
  ident: 2021080915435765800_R26
  article-title: An introduction to instrumental variable assumptions, validation and estimation.
  publication-title: Emerg Themes Epidemiol
  doi: 10.1186/s12982-018-0069-7
  contributor:
    fullname: Lousdal
– volume: 113 Suppl 1
  start-page: i63
  year: 2014
  ident: 2021080915435765800_R6
  article-title: Differential effects of serum from patients administered distinct anaesthetic techniques on apoptosis in breast cancer cells in vitro: A pilot study.
  publication-title: Br J Anaesth
  doi: 10.1093/bja/aet581
  contributor:
    fullname: Jaura
– volume: 36
  start-page: 159
  year: 2017
  ident: 2021080915435765800_R5
  article-title: Anesthetic technique and cancer recurrence in oncologic surgery: Unraveling the puzzle.
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/s10555-016-9647-8
  contributor:
    fullname: Kim
– volume: 7
  start-page: 26042
  year: 2016
  ident: 2021080915435765800_R18
  article-title: Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells.
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8304
  contributor:
    fullname: Iwasaki
– volume: 38
  start-page: 1228
  year: 2009
  ident: 2021080915435765800_R13
  article-title: Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.
  publication-title: Commun Stat Simul Comput
  doi: 10.1080/03610910902859574
  contributor:
    fullname: Austin
– volume: 111
  start-page: 1338
  year: 2014
  ident: 2021080915435765800_R16
  article-title: Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination.
  publication-title: Br J Cancer
  doi: 10.1038/bjc.2014.426
  contributor:
    fullname: Huang
– volume: 120
  start-page: 368
  year: 2018
  ident: 2021080915435765800_R17
  article-title: Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro.
  publication-title: Br J Anaesth
  doi: 10.1016/j.bja.2017.11.066
  contributor:
    fullname: Ciechanowicz
– volume: 124
  start-page: 69
  year: 2016
  ident: 2021080915435765800_R22
  article-title: Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: A retrospective analysis.
  publication-title: Anesthesiology
  doi: 10.1097/ALN.0000000000000936
  contributor:
    fullname: Wigmore
– volume: 173
  start-page: 676
  year: 2011
  ident: 2021080915435765800_R12
  article-title: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwq433
  contributor:
    fullname: Quan
– volume: 119
  start-page: 593
  year: 2013
  ident: 2021080915435765800_R1
  article-title: Isoflurane, a commonly used volatile anesthetic
  publication-title: Anesthesiology
  doi: 10.1097/ALN.0b013e31829e47fd
  contributor:
    fullname: Benzonana
– volume: 36
  start-page: 1327
  year: 2013
  ident: 2021080915435765800_R7
  article-title: Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100β protein during coronary artery bypass grafting.
  publication-title: Inflammation
  doi: 10.1007/s10753-013-9671-6
  contributor:
    fullname: Baki
– volume: 65
  start-page: 557
  year: 1997
  ident: 2021080915435765800_R15
  article-title: Instrumental variables regression with weak instruments.
  publication-title: Econometrica
  doi: 10.2307/2171753
  contributor:
    fullname: Staiger
– volume: 831
  start-page: 46
  year: 2018
  ident: 2021080915435765800_R4
  article-title: Effects of propofol on cancer development and chemotherapy: Potential mechanisms.
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2018.04.009
  contributor:
    fullname: Jiang
– volume: 113 Suppl 1
  start-page: i56
  year: 2014
  ident: 2021080915435765800_R2
  article-title: Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: A pilot study.
  publication-title: Br J Anaesth
  doi: 10.1093/bja/aeu200
  contributor:
    fullname: Buckley
– volume: 37
  start-page: 587
  year: 2017
  ident: 2021080915435765800_R19
  article-title: Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.
  publication-title: Oncol Rep
  doi: 10.3892/or.2016.5218
  contributor:
    fullname: Yang
– volume: 66
  start-page: 1007
  year: 2019
  ident: 2021080915435765800_R10
  article-title: Correction to: Anesthetic technique and cancer outcomes: A meta-analysis of total intravenous versus volatile anesthesia.
  publication-title: Can J Anaesth
  doi: 10.1007/s12630-019-01381-0
  contributor:
    fullname: Yap
– volume: 26
  start-page: 414
  year: 2015
  ident: 2021080915435765800_R27
  article-title: Definition and evaluation of the monotonicity condition for preference-based instruments.
  publication-title: Epidemiology
  doi: 10.1097/EDE.0000000000000279
  contributor:
    fullname: Swanson
– volume: 27
  start-page: 476
  year: 2017
  ident: 2021080915435765800_R11
  article-title: Validity of diagnoses, procedures, and laboratory data in Japanese administrative data.
  publication-title: J Epidemiol
  doi: 10.1016/j.je.2016.09.009
  contributor:
    fullname: Yamana
– volume: 35
  start-page: 1311
  year: 2015
  ident: 2021080915435765800_R3
  article-title: Effect of anaesthetic technique on immune cell infiltration in breast cancer: A follow-up pilot analysis of a prospective, randomised, investigator-masked study.
  publication-title: Anticancer Res
  contributor:
    fullname: Desmond
– volume: 37
  start-page: 2611
  year: 2017
  ident: 2021080915435765800_R20
  article-title: Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
  publication-title: Oncol Rep
  doi: 10.3892/or.2017.5514
  contributor:
    fullname: Yang
– volume: 42
  start-page: 19
  year: 2017
  ident: 2021080915435765800_R21
  article-title: Outcomes of cancer surgery after inhalational and intravenous anesthesia: A systematic review.
  publication-title: J Clin Anesth
  doi: 10.1016/j.jclinane.2017.08.001
  contributor:
    fullname: Soltanizadeh
– volume: 11
  start-page: 1141
  year: 2018
  ident: 2021080915435765800_R24
  article-title: Effects of propofol-based total intravenous anesthesia on gastric cancer: A retrospective study.
  publication-title: Onco Targets Ther
  doi: 10.2147/OTT.S156792
  contributor:
    fullname: Zheng
– volume: 130
  start-page: 31
  year: 2019
  ident: 2021080915435765800_R23
  article-title: Total intravenous anesthesia versus inhalation anesthesia for breast cancer surgery: A retrospective cohort study.
  publication-title: Anesthesiology
  doi: 10.1097/ALN.0000000000002491
  contributor:
    fullname: Yoo
– volume: 119
  start-page: 251
  year: 2014
  ident: 2021080915435765800_R25
  article-title: The choice of anaesthetic–sevoflurane or propofol–and outcome from cancer surgery: A retrospective analysis.
  publication-title: Ups J Med Sci
  doi: 10.3109/03009734.2014.922649
  contributor:
    fullname: Enlund
– volume: 15
  start-page: 6703
  year: 2014
  ident: 2021080915435765800_R9
  article-title: Influence of propofol, isoflurane and enflurance on levels of serum interleukin-8 and interleukin-10 in cancer patients.
  publication-title: Asian Pac J Cancer Prev
  doi: 10.7314/APJCP.2014.15.16.6703
  contributor:
    fullname: Liu
SSID ssj0007538
Score 2.385459
Snippet Background Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were...
BACKGROUNDPrevious experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 764
Title Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery
URI https://search.proquest.com/docview/2442844750
Volume 133
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NbxMxELVCuXBBIECULxmJW7Ql3vV-HaMCCpRWSKSonFZ21lFWpbtVdvcAv4sfyIxn7SRthSg5bCIrshLP0_h5PPOGsTdA2kyYhmVQTowMpMZG7iivrfNYK7yISW0tzPFJMjuVn87is9Ho91bWUt_pg8WvG-tK_seqMAZ2xSrZW1jWTwoD8BnsC0-wMDz_ycbfGsxk-2HGmFvRt-N501npjA57Clnt1Sl4MqB4baVsPuEh2niN1QGYX1fZXNgvpKzajmfKBhfoygkTioZvf71eOe2nJQUnYKkYmEHFycsVZt_66MIxEFTbqGl8pGp13mzGu7anhtnVujmvPIz6dlVdUIZB9bNZVaUH3nfV9rWiOPAMxpvtgAWcTl3q28YJR0E0oXLkAzP43RAOs4KaqHjHTBIZAwLllptNSfl82LFTaoZybTMgkeHp5xMSqRxekSR9qF3t7St7os9UdHf0MEtxdZY77G4I7g0TCd99PPL7PxwAM9enEf-mK9jM07c3_ZZdQrTLByzJmT9g94fTCZ8S1B6ykakfsQsHM04w4xZmfAtmfAMzDjDjBBzuYcarmjuYcYIZ9zBz3x5g9pidfng_P5wFQ5eOYIGdzgKZ5MkiToXQOapJSiUUUESpQ6WADkZxqUollyYx6WQRLSUsjoD3DHYKk8XahNETtlc3tXnKeBYKLZUWucSwRZlkWiuYallGQpVJLvZZ4JaquCQxluJvBtpnr916FuA18SpM1QaWpQBSC7xMAl1-dss5n7N7G1C_YHvdujcvgZd2-pWFwR-QJYhc
link.rule.ids 315,783,787,27938,27939
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Volatile+versus+Total+Intravenous+Anesthesia+for+Cancer+Prognosis+in+Patients+Having+Digestive+Cancer+Surgery&rft.jtitle=Anesthesiology+%28Philadelphia%29&rft.au=Makito%2C+Kanako&rft.au=Matsui%2C+Hiroki&rft.au=Fushimi%2C+Kiyohide&rft.au=Yasunaga%2C+Hideo&rft.date=2020-10-01&rft.issn=0003-3022&rft.eissn=1528-1175&rft.volume=133&rft.issue=4&rft.spage=764&rft.epage=773&rft_id=info:doi/10.1097%2FALN.0000000000003440&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_ALN_0000000000003440
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-3022&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-3022&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-3022&client=summon